GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laekna Inc (HKSE:02105) » Definitions » Enterprise Value

Laekna (HKSE:02105) Enterprise Value : HK$1,953.55 Mil (As of May. 29, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Laekna Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Laekna's Enterprise Value is HK$1,953.55 Mil. Laekna's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-771.26 Mil. Therefore, Laekna's EV-to-EBIT ratio for today is -2.53.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Laekna's Enterprise Value is HK$1,953.55 Mil. Laekna's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-771.26 Mil. Therefore, Laekna's EV-to-EBITDA ratio for today is -2.53.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Laekna's Enterprise Value is HK$1,953.55 Mil. Laekna's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.00 Mil. Therefore, Laekna's EV-to-Revenue ratio for today is .


Laekna Enterprise Value Historical Data

The historical data trend for Laekna's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laekna Enterprise Value Chart

Laekna Annual Data
Trend Dec21 Dec22 Dec23
Enterprise Value
- - 6,972.68

Laekna Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Enterprise Value - - - 5,634.40 6,972.68

Competitive Comparison of Laekna's Enterprise Value

For the Biotechnology subindustry, Laekna's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laekna's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Laekna's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Laekna's Enterprise Value falls into.



Laekna Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Laekna's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Laekna's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laekna  (HKSE:02105) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Laekna's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1953.545/-771.262
=-2.53

Laekna's current Enterprise Value is HK$1,953.55 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Laekna's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-771.26 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Laekna's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=1953.545/-771.262
=-2.53

Laekna's current Enterprise Value is HK$1,953.55 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Laekna's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-771.26 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Laekna's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1953.545/0
=

Laekna's current Enterprise Value is HK$1,953.55 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Laekna's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laekna Enterprise Value Related Terms

Thank you for viewing the detailed overview of Laekna's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Laekna (HKSE:02105) Business Description

Traded in Other Exchanges
N/A
Address
No. 987, Cailun Road, 5th Floor, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN, 201203
Laekna Inc is a science-driven, clinical-stage biotechnology company. The company has established a comprehensive R&D infrastructure to accelerate the development of molecules from discovery to registrational trials. It has initiated one clinical trial and another five clinical trials for its Core Products LAE002 and LAE001. Among these six clinical trials, three multi-regional clinical trials (MRCTs) are designed to address medical needs in the standard of care (SOC)-resistant cancers. Laekna has two Core Products and 14 other pipeline product candidates. Core Product LAE002 is an adenosine triphosphate (ATP) competitive AKT inhibitor for the treatment of ovarian cancer, prostate cancer, breast cancer and PD-1/PD-L1 drug-resistant solid tumors.
Executives
Gp Healthcare Capital, Inc. 2101 Beneficial owner
Shang Hai Jin Pu Yi Liao Jian Kang Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Shang Hai Jin Pu Yi Liao Jian Kang Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Liu Zeng 2201 Interest of corporation controlled by you
Zhong Yi Ning Bo Sheng Tai Yuan Kong Gu Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Ning Bo Yao Shang Yan Chuang Si Mu Ji Jin Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Ning Bo Yao Shang Yan Chuang Shou Ren Gu Quan Tou Zi You Xian Gong Si 2201 Interest of corporation controlled by you
Ning Bo Yan Chuang Hou De Tou Zi Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Bei Jing Chun Lin Xin Xi Zi Xun Zhong Xin You Xian He Huo 2201 Interest of corporation controlled by you
Bei Jing An Long Chuang Ye Tou Zi Ji Jin You Xian He Huo 2201 Interest of corporation controlled by you
Liu Ying 2201 Interest of corporation controlled by you
Guo Tou Zhao Shang Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Xian Jin Zhi Zao Chan Ye Tou Zi Ji Jin Er Qi You Xian He Huo 2101 Beneficial owner
Yu Yao Yang Ming Gu Quan Tou Zi Ji Jin You Xian Gong Si 2101 Beneficial owner
Futu Trustee Limited 2301 Trustee

Laekna (HKSE:02105) Headlines

No Headlines